Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Chromosome Abnormalities and Psychotropic Drugs

Abstract

DURING a study of chromosome abnormalities in five patients treated with d-lysergic acid diethylamide (LSD) we examined thirty patients in a mental hospital and ten hospital staff members as controls. The frequency of gaps was significantly higher in the thirty patients than in the staff members group (χ2 = 6.859, P < 0.01). When we divided the control group of patients into those treated with drugs and those not treated with drugs, we found that the frequency of gaps and breaks in the group treated with drugs was significantly higher than in the group of patients not treated with drugs (χ2 = 10.399, P < 0.005, P(Fisher) = 0.037, Table 1).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

NIELSEN, J., FRIEDRICH, U. & TSUBOI, T. Chromosome Abnormalities and Psychotropic Drugs. Nature 218, 488–489 (1968). https://doi.org/10.1038/218488b0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/218488b0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing